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BRIEF DEFINITIVE REPORT
Gαs-coupled receptor signaling and sleep regulate
integrin activation of human antigen-speciﬁc T cells
Stoyan Dimitrov1,2,3*, Tanja Lange4*, Ce´cile Gouttefangeas5, Anja T.R. Jensen6, Michael Szczepanski1, Jannik Lehnnolz1, Surjo Soekadar1,7,
Hans-Georg Rammensee5,8, Jan Born1,2,3, and Luciana Besedovsky1
Efﬁcient T cell responses require the ﬁrm adhesion of T cells to their targets, e.g., virus-infected cells, which depends on T cell
receptor (TCR)–mediated activation of β2-integrins. Gαs-coupled receptor agonists are known to have immunosuppressive
effects, but their impact on TCR-mediated integrin activation is unknown. Using multimers of peptide major
histocompatibility complex molecules (pMHC) and of ICAM-1—the ligand of β2-integrins—we show that the Gαs-coupled
receptor agonists isoproterenol, epinephrine, norepinephrine, prostaglandin (PG) E2, PGD2, and adenosine strongly inhibit
integrin activation on human CMV- and EBV-speciﬁc CD8+ T cells in a dose-dependent manner. In contrast, sleep, a natural
condition of low levels of Gαs-coupled receptor agonists, up-regulates integrin activation compared with nocturnal
wakefulness, a mechanism possibly underlying some of the immune-supportive effects of sleep. The ﬁndings are also relevant
for several pathologies associated with increased levels of Gαs-coupled receptor agonists (e.g., tumor growth, malaria,
hypoxia, stress, and sleep disturbances).
Introduction
The initiation and execution of efﬁcient T cell responses require
the recruitment of T cells to lymphoid and nonlymphoid tissues
(Ley et al., 2007), as well as the formation of immunological
synapses with antigen-presenting cells (APCs) or target cells
(such as virus-infected or cancer cells; Scholer et al., 2008;
Dustin and Long, 2010; Fooksman et al., 2010). The modulation
of T cell adhesiveness by regulation of integrin activation is
crucial to these steps. Recirculating T lymphocytes express high
levels of membrane-bound β2-integrins (Dimitrov et al., 2009,
2010), which are maintained in a nonadhesive (inactive) state
(Evans et al., 2009). Immediate activation (i.e., increase in af-
ﬁnity and avidity) of β2-integrins induced by chemokines allows
the arrest of T cells on the endothelium and their subsequent
extravasation into tissues (Ley et al., 2007). A similar activation
of β2-integrins in response to TCR engagement by cognate
peptides presented by MHC molecules (pMHC) on APCs or
target cells is also required for the formation of stable immu-
nological synapses (Dustin and Springer, 1989; Dustin and Long,
2010; Fooksman et al., 2010; Long, 2011).
Research on the regulation of integrin-mediated adhesion has
focused over the past 35 yr exclusively on pro-adhesive signals,
such as chemokines and pMHC. Only recently, the existence of
anti-adhesive factors, such as Gαs (a heterotrimeric G protein
subunit that activates the cAMP-dependent pathway)-coupled
receptor agonists, nitric oxide, and carbon monoxide has be-
come evident (Chigaev et al., 2008, 2011a,b, 2014). Speciﬁcally, it
has been shown in monocytes that the chemokine-induced in-
tegrin afﬁnity is down-regulated by anti-adhesive signaling
derived fromGαs-coupled receptor agonists like amthamine (H2-
histaminergic receptor agonist) and isoproterenol (β1/2-adre-
nergic receptor [AR] agonist; Chigaev et al., 2008, 2011b). The
recruitment of cytotoxic leukocytes to the blood during daytime
and acute physical or psychological stress has been suggested to
be mediated by epinephrine (a β1/2-AR agonist), which induces a
down-regulation of integrins, resulting in the de-adhesion of the
cells from the endothelium of the marginal pool (Dimitrov et al.,
2009, 2010). However, nothing is known about the effect of
epinephrine or other Gαs-coupled receptor agonists on TCR-
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mediated integrin activation and formation of immunological
synapses.
Several signalingmolecules, including catecholamines (Wahle
et al., 2005), prostaglandins (PGs; Scher and Pillinger, 2009;
Kalinski, 2012), adenosine (Hoskin et al., 2008), dopamine (Yan
et al., 2015), histamine, and serotonin (Kim et al., 2013) exert anti-
inﬂammatory effects via their cognate Gαs-coupled receptors.
Given the common intracellular mediator cAMP, here we asked
whether these substances also share anti-adhesive properties.
Sleep is known as a condition characterized by low levels of en-
dogenous Gαs-coupled receptor agonists such as catecholamines
(Dimitrov et al., 2015), PGs (Haack et al., 2009), and serotonin
(Davies et al., 2014). We therefore additionally used sleep as an
in vivo readout to assess effects of low levels of Gαs-coupled re-
ceptor agonists on adhesive properties of antigen-speciﬁc T cells
in a physiological condition. In addition, because of the strong
circadian rhythm in the levels of catecholamines (Dimitrov et al.,
2015), PGs (Kamperis et al., 2004), serotonin (Davies et al., 2014),
and adenosine (Chagoya de Sa´nchez et al., 1983), with a nadir
during the rest phase, adhesion was measured across an entire
day to detect a possible circadian rhythm of this parameter. For
these purposes, we recruited healthy humans seropositive for
CMV, because this chronic latent infection is characterized by a
high number of antigen-speciﬁc T cells, allowing for the analysis
of different T cell subsets. Adhesive properties of the cells were
assessed by a new ﬂow cytometry–based assay using soluble
pMHC multimers for staining and activation of the antigen-
speciﬁc T cells, and ﬂuorescent intercellular adhesion molecule
(ICAM)–1 multimers (mICAM-1) for visualization of activated β2-
integrins (Dimitrov et al., 2018).
We show that catecholamines, PGE2, PGD2, and adenosine
potently inhibit TCR-mediated integrin activation on human
antigen-speciﬁc CD8+ T cells, even at low (physiological) con-
centrations, whereas nocturnal sleep up-regulates integrin ac-
tivation by reducing Gαs-coupled receptor signaling. Our
ﬁndings support the view that conditions of low levels of
Gαs-coupled receptor agonists, as generated during sleep, favor
the formation of immunological synapses and thereby enhance
T cell responses.
Results and discussion
Epinephrine potently inhibits pMHC multimer-induced
activation of β2-integrins on antigen-speciﬁc CD8+ T cells
We have recently developed a whole blood ﬂow cytometry–
based assay tomonitor β2-integrin activation on antigen-speciﬁc
CD8+ T cells by staining the cells with mICAM-1 upon antigen-
speciﬁc stimulation (Dimitrov et al., 2018). Up-regulation of
integrin activation on T cells occurs within a few minutes after
TCR engagement and is, so far, the earliest measurable correlate
of T cell functionality (as measured by cytokine production and
expression of cytotoxic markers) following stimulation
(Dimitrov et al., 2018). Thus, this assay is optimal for detecting
acute effects of endogenous, fast-acting substances like cate-
cholamines on T cell function.
We ﬁrst tested the effect of epinephrine at very low (10−10 M),
stress/exercise-like (10−9 M), and high (10−8M; pathophysiological,
such as during hypoglycemia) concentrations on integrin activa-
tion.Whole blood fromﬁveHLA-A2+ and CMV-seropositive donors
was coincubated with A2/NLV (CMV) or A2/GLC (EBV) pMHC
multimers and mICAM-1 for 5 min. The gating strategy to identify
CD8+ T cells is shown in Fig. 1 A. As previously shown (Dimitrov
et al., 2018), more than two-thirds of A2/NLV+ cells and approxi-
mately 30% (with a large inter-individual variability) of A2/GLC+
cells were mICAM-1+ (left plots on Fig. 1, B and C, respectively,
shown for one representative CMV- and EBV-seropositive donor;
and Table 1). Preincubation of the blood cells for 5 min with epi-
nephrine reduced β2-integrin activation by one-fourth to one-third
at the lowest concentration and by 80% at stress/exercise-like
levels, and almost completely inhibited it at high concentrations
(Fig. 1, B and C; and Fig. 2, A and B). Previous assays assessing the
effect of Gαs-coupled receptor agonists on integrin activation in
monocytes relied on cell lines or processed blood, thus not allowing
analysis of fast and ﬁne-tuning effects relevant for in vivo sit-
uations (Chigaev et al., 2008, 2011b). In contrast, costaining of
whole blood cells with pMHC and mICAM-1 proved to be a simple
and sensitive method for detecting fast changes in β2-integrin ac-
tivation on antigen-speciﬁc T cells induced by even very low
physiological levels of epinephrine.
Gαs-coupled receptor agonists down-regulate TCR-induced
integrin activation on CMV- and EBV-speciﬁc T cells
Next, we determined the effect and relative potency of different
Gαs-coupled receptor agonists on the regulation of β2-integrin
activation. Isoproterenol, epinephrine, norepinephrine, PGE2,
PGD2, and adenosine down-regulated β2-integrin activation in a
dose-dependent and agonist-speciﬁc manner, whereas dopa-
mine, histamine, and serotonin had no effect (Fig. 2).
The effective concentration generating 50% of the effect
(EC50) for CMV-speciﬁc cells was ∼2× higher for epinephrine
and 200× higher for norepinephrine compared with isoprote-
renol (Fig. 2 A and Table 1). This suggests that the effect is
mediated by β2-ARs (rather than by β1- or β3-ARs), as the rela-
tive degree of binding afﬁnity to the β2-AR and the impact on
cAMP production following receptor activation follows the same
order (isoproterenol ≈ 2× epinephrine  norepinephrine;
Hoffmann et al., 2004). Indeed, the inhibitory effect of epi-
nephrine and norepinephrine was entirely abolished by pre-
incubation with an antagonist of the Gαs-coupled β2-AR (Fig. S1).
Reduction of integrin activation ﬁrst became signiﬁcant at a
concentration of 5 × 10−11 M for isoproterenol (P = 0.031), at 10−10
M for epinephrine (P = 0.047), and at 10−8 M for norepinephrine
(P = 0.016). Almost complete inhibition was achieved at iso-
proterenol and epinephrine concentrations of 10−8 M and at a
norepinephrine concentration of 10−6 M.
PGE2 and PGD2 inhibited β2-integrin activation with similar
EC50 on CMV-speciﬁc cells (Fig. 2 C and Table 1). Both PGs
achieved a maximal effect at 10,000 pg/ml. However, PGE2 was
more effective at lower concentrations: reduction of integrin
activation ﬁrst reached signiﬁcance at a concentration of 100 pg/
ml for PGE2 (P = 0.046) and 333 pg/ml for PGD2 (P = 0.044). The
inhibitory effect of PGD2 was completely blocked after pre-
incubation with an antagonist of the Gαs-coupled PGD2 receptor
DP1 (Fig. S1). The effect of PGE2 was reversed by blocking the
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high-afﬁnity Gαs-coupled PGE2 receptor EP4, but not by blocking
the low-afﬁnity receptor EP2 (presumably because we did not
use very high levels of PGE2 [1,000 pg/ml]).
Adenosine inhibited integrin activation when peripheral
blood mononuclear cells (PBMCs) were used (EC50: 9.6 × 10−8 M;
Fig. 2 E), but was ineffective when using whole blood (probably
due to the fast reuptake of adenosine by erythrocytes and the
consequently extremely short half-life [<1 s] of this substance in
whole blood; Ramakers et al., 2008). The reduction of integrin
activation became signiﬁcant at the lowest dose used (10−8 M;
P = 0.045) and achieved a maximal effect at 10−5 M. No effect
was observed for the other Gαs-coupled receptor agonists tested
(Fig. 2 F). Although there is some evidence for an immuno-
modulatory effect of serotonin, dopamine, and histamine, this
Figure 1. Epinephrine potently inhibits pMHC
multimer-induced β2-integrin activation on
antigen-speciﬁc CD8+ T cells. Human whole blood
cells were incubated for 5 min at 37°C in the pres-
ence of pMHCmultimers (A2-NLV/PE or A2-GLC/PE)
and mICAM-1. (A) Representative density plots
showing the gating strategy used for deﬁning
pMHC+ CD8+ T cells. From left to right, the lym-
phocyte gate (on the forward scatter area [FSC-A]/
side scatter area [SSC-A] plot), the FSC-A/FSC
height (FSC-H) duplet exclusion, the gating of
CD3+CD8+ cells, and the exclusion of CD4+, CD14+,
and CD19+ events are shown. (B and C) CMV-speciﬁc
(B) and EBV-speciﬁc (C) CD8+ T cells were stained with
A2-NLV/PE or A2-GLC/PE multimers, respectively.
Multimer binding to the TCR leads to activation of
β2-integrins (left), which was detected by staining
with mICAM-1. Preincubation of the cells for 5 min
with 10−10 M (18 pg/ml), 10−9 M (180 pg/ml), or 10−8
M (1,800 pg/ml) epinephrine partially or completely
blocked the activation of the β2-integrins. Numbers
indicate the MFI of mICAM-1 binding on pMHC+ CD8+
T cells, and italic numbers in brackets indicate the
frequency of mICAM-1+ cells among pMHC+ CD8+
T cells.
Table 1. Characteristics of CMV- and EBV-speciﬁc cells and EC50 values of Gαs-coupled receptor agonists
Total CMV-
speciﬁc cells
Early differentiated CMV-
speciﬁc cells
Intermediate differentiated
CMV-speciﬁc cells
Late differentiated
CMV-speciﬁc cells
Total EBV-
speciﬁc cells
% of A2-NLV+ or
A2-GLC+ ± SEM
100 32.8 ± 4.0 32.9 ± 5.1 30.6 ± 5.8 100
% mICAM-1+ ± SEM 83.0 ± 3.7 77.6 ± 4.6 83.5 ± 3.6 85.9 ± 5.0 30.3 ± 8.8
MFI of mICAM-1+ ± SEM 12,730 ± 1,904 8,459 ± 1,081 13,596 ± 1,796* 15,423 ± 3,198* 2,325 ± 988
EC50 of isoproterenol, M 1.4 × 10−10 1.27 × 10−10 1.47 × 10−10 1.58 × 10−10 9.9 × 10−11
EC50 of epinephrine, M 3.9 × 10−10 3.20 × 10−10 4.15 × 10−10* 3.94 × 10−10* 2.5 × 10−10
EC50 of norepinephrine, M 3.2 × 10−8 3.22 × 10−8 3.04 × 10−8 3.62 × 10−8 1.2 × 10−8
EC50 of PGE2, pg/ml 931 504 1,135* 1,073* 303
EC50 of PGD2, pg/ml 797 606 737 810 952
*, P ≤ 0.05 for comparisons between early versus intermediate or late differentiated CMV-speciﬁc T cells.
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ﬁnding can probably be explained by the lack or relatively low
expression of intact Gαs-coupled receptors for these neuro-
transmitters on T cells (Saha et al., 2001a,b; León-Ponte et al.,
2007; Kmiecik et al., 2012).
The inhibitory effect of Gαs-coupled receptor agonists does
not seem to be limited to particular antigen-speciﬁc T cells, as
we found similar results for EBV-speciﬁc CD8+ T cells (Fig. 2, B
and D; and Table 1). Here, reduction of integrin activation ﬁrst
became signiﬁcant at a concentration of 10−10 M for isoprote-
renol (P = 0.032), 3.3 × 10−9 M for epinephrine (P = 0.032), 10−8
M for norepinephrine (P = 0.037), and 333 pg/ml for PGE2 and
PGD2 (P ≤ 0.042). Maximum inhibition was achieved at iso-
proterenol and epinephrine concentrations of 10−8 M, at a nor-
epinephrine concentration of 10−6 M, and for both PGs at
concentrations of 10,000 pg/ml.
Catecholamines, PGs, and adenosine are known to directly
suppress the production of cytokines and T cell proliferation
(Wahle et al., 2005; Hoskin et al., 2008; Kalinski, 2012; Leone
et al., 2015a). Our ﬁndings showing that these Gαs-coupled re-
ceptor ligands impair integrin activation reveal a new mecha-
nism by which these molecules can exert immunosuppressive
effects. Because the levels of Gαs-coupled receptor agonists
needed to inhibit integrin activation ex vivo are observed in
many physiological and pathological conditions, such as tumor
growth, certain infections, hypoxia, and stress, these substances
can bewell expected to contribute to immunosuppressive effects
in vivo (Lokshin et al., 2006; Brudvik and Taske´n, 2012; Kalinski,
2012; Leone et al., 2015a,b).
Gαs-coupled receptor agonists down-regulate TCR-induced
integrin activation depending on the differentiation status of
CMV-speciﬁc T cells
We then tested whether mICAM-1 binding and the effects of
Gαs-coupled receptor agonists depend on the differentiation
status of antigen-speciﬁc T cells. As shown previously (Appay
et al., 2002, 2008), CMV- and EBV-speciﬁc CD8+ T cells can be
separated into three differentiation subsets: early (CD27+CD28+),
intermediate (CD27+CD28−) and late (CD27−CD28−) differenti-
ated cells, based on their CD27 and CD28 expression. For CMV-
speciﬁc cells, percentages of the three subpopulations were
similar (Table 1 and Fig. S2 A), whereas EBV-speciﬁc cells were
highly enriched in the early differentiated subset (70.3% ± 7.1%).
The mean ﬂuorescence intensity (MFI) of mICAM-1 binding
was higher on intermediate and late differentiated compared
with early differentiated cells (Table 1 and Fig. S2 B). The inhi-
bition of integrin activation by epinephrine and PGE2 was
strongest for the early differentiated cells, but there were no
signiﬁcant differences between subsets for the EC50 of isopro-
terenol, norepinephrine, and PGD2 (Table 1 and Fig. S2, C and D).
The ﬁnding that epinephrine was more effective in reducing
integrin activation in early compared with intermediate and late
differentiated cells might be surprising, given that this subset
Figure 2. Effect of Gαs-coupled receptor ag-
onists on pMHC-induced β2-integrin activa-
tion on antigen-speciﬁc CD8+ T cells. (A–F)
Whole blood cells and (for adenosine) PBMCs
were preincubated in the presence or absence of
the indicated Gαs-coupled receptor agonists at
the indicated concentrations for 5 min followed
by staining with CMV A2-NLV/PE (A, C, E, and F)
or EBV A2-GLC/PE (B and D) multimers and
mICAM-1 for 5 min at 37°C. Means ± SEM of the
MFI of mICAM-1 binding are shown for the dif-
ferent agonists as percentage of the control
(i.e., the sample without Gαs-coupled receptor
agonists, which was set to 100%). The ﬁtted
standard curves were calculated by nonlinear
regression; n = 5 (n = 3 for adenosine, serotonin,
histamine, and dopamine).
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expresses the lowest number of β2-adrenoreceptors (Dimitrov
et al., 2009, 2010). However, it is not uncommon that receptor
expression levels do not correlate with the cell’s responsiveness
to a substance (Dimitrov et al., 2009), pointing to the presence of
other factors, such as the molecules involved in the intracellular
signaling cascade, that contribute to the magnitude of the sub-
stance effect as well.
Sleep increases β2-integrin activation on CMV- and
EBV-speciﬁc CD8+ T cells
Given that nocturnal sleep is characterized by low levels of
Gαs-coupled agonists, such as catecholamines and PGs, we
compared effects of sleep versus nocturnal wakefulness on β2-
integrin activation of CMV- and EBV-speciﬁc T cells. In a within-
subject design, healthy CMV-positive participants spent one
night in the sleep laboratory with sleep allowed between 11 pm
and 7 am (sleep condition) and another night in which partic-
ipants had to stay awake in bed during the same period (wake
condition). Whole blood for the determination of integrin acti-
vationwas collected repeatedly across an entire day, additionally
enabling the detection of circadian rhythms.
Compared with the wake condition, sleep signiﬁcantly in-
creased the MFI of mICAM-1 binding on pMHC+ CD8+ T cells
(F(1,9) = 4.1; P = 0.05 and F(1,8) = 6.0; P = 0.05 for sleep/wake × period
effect for CMV- and EBV-speciﬁc CD8+ T cells, respectively; see
Fig. 3, A and B, for comparisons at single time points). For CMV-
speciﬁc T cells, the effect was evident already at 2 am (i.e., 3 h after
the beginning of the sleep opportunity). Cosinor analysis conﬁrmed
a signiﬁcant circadian rhythm in mICAM-1 binding on CMV- and
EBV-speciﬁc cells during the regular sleep–wake cycle (P ≤ 0.023;
Fig. 3, A and B), which was abolished in the wake condition (P =
0.07 and 0.10 for CMV- and EBV-speciﬁc cells, respectively). The
ﬁtted cosine curve for the sleep–wake cycle showed an acrophase
(peak time) at 3:33 am± 32min and 4:15 am± 50min for CMV- and
EBV-speciﬁc cells, respectively.
Our results demonstrate that a couple of hours of sleep loss
sufﬁce to reduce the adhesion capacity of antigen-speciﬁc
T cells. This ﬁnding shows that sleep has the potential to en-
hance the efﬁciency of effector T cell responses, which is espe-
cially relevant in light of the high prevalence of sleep disorders
and conditions characterized by impaired sleep, such as de-
pression, chronic stress, aging, and shift work (Akerstedt, 2003;
Roth, 2007; Medina et al., 2014; Feinsilver and Hernandez, 2017).
Sleep selectively increases β2-integrin activation on early and
intermediate differentiated CMV-speciﬁc CD8+ T cell subsets
mICAM-1 binding at baseline (10 pm) across the sleep and wake
conditions was lowest in early differentiated cells (3,889 ± 570),
higher in the intermediate differentiated subset (7,479 ± 1,055),
and highest in late differentiated cells (8,868 ± 1,135; P ≤ 0.003
for early vs. intermediate, early vs. late, and intermediate vs late
differentiated cells; Fig. 3, C–E). Compared with the wake con-
dition, sleep signiﬁcantly increased mICAM-1 binding on pMHC+
CD8+ T cells for the early and intermediate differentiated cells
(F(1,9) = 7.7; P = 0.02 and F- = 4.6; P = 0.005 for sleep/wake ×
period effect, respectively; see Fig. 3 for comparisons at single
time points). Cosinor analysis conﬁrmed a signiﬁcant rhythm in
mICAM-1 binding for all three subsets during the regular
sleep–wake cycle (P ≤ 0.033), which descriptively was most
pronounced for the early differentiated cells: with reference to
peak values, mICAM-1 binding during nadir times was reduced
by 33%, 30%, and 26%, respectively, in the three subpopulations.
The ﬁtted cosine curve showed an acrophase at 4:13 am ± 84 min
for the early differentiated subset, at 2:19 am ± 76 min for the
intermediate differentiated subset, and at 3:01 am ± 68 min for
the late differentiated subset. Peak values of mICAM-1 binding
(as derived from cosinor analyses) were signiﬁcantly higher in
the sleep condition compared with the wake condition (P ≤
0.01), with a similar percentage change in all three sub-
populations (57%, 56%, and 56%, respectively).
We could not measure integrin activation on undifferentiated
(i.e., naive) T cells due to the inherent properties of the applied
assay. However, because the early differentiated phenotype was
the most responsive one, it is likely that adhesive properties of
Figure 3. Sleep increases β2-integrin activa-
tion on antigen-speciﬁc CD8+ T cells. (A–E)
Means ± SEM of the MFI of mICAM-1 binding on
total CMV-speciﬁc (A) and EBV-speciﬁc (B) CD8+
T cells, as well as on early (CD27+CD28+; C),
intermediate (CD27+CD28−; D) and late
(CD27−CD28−; E) differentiated CMV-speciﬁc
CD8+ T cell subpopulations after staining with
pMHC multimers and mICAM-1 are shown for a
regular sleep–wake cycle (sleep, ﬁlled circles)
and continuous wakefulness (wake, open cir-
cles). Gray lines illustrate adapted cosine curves
for conﬁrmed circadian rhythms in the sleep
condition; the shaded area depicts bedtime.
Signiﬁcance is indicated for pairwise compar-
isons between conditions using paired t tests
following signiﬁcant ANOVA results. n = 10 for
CMV; n = 5 for EBV; *, P < 0.05.
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naive T cells are also affected by Gαs-coupled receptors. Previous
experiments have shown that sleep is essential for forming
adaptive immune responses, which has been most impressively
demonstrated by several studies using vaccination (Lange et al.,
2003, 2011; Benedict et al., 2012). The mechanisms of this
boosting effect of sleep on antigen-speciﬁc responses are not
well understood. If ourﬁndings are indeed transferrable to naive
T cells, an increased adhesion of naive T cells to APCs might at
least partly explain the adjuvant-like effect of sleep on vacci-
nation responses, thus revealing a novel mechanism underlying
this effect.
Sleep regulates β2-integrin activation by suppression of
Gαs-coupled receptor signaling
Next, we tested whether the effect of sleep versus wakefulness
on integrin activation is mediated by soluble factors via a
Gαs-coupled receptor–dependent way. We collected heparin
plasma from healthy participants on one night while they were
asleep and on another night while they stayed awake in bed. We
then incubated cells from a sleeping CMV-positive donor with
the plasma collected during the two conditions (sleep vs. wake)
in the presence or absence of Gαs-coupled receptor agonists or
antagonists to compare integrin activation. These plasma ex-
periments conﬁrmed our ﬁndings on a sleep-induced increase in
integrin activation: Incubation of CMV-speciﬁc cells with plas-
ma collected at 2 am (i.e., the time point of signiﬁcant differ-
ences between sleep and wakefulness in the foregoing sleep
experiment) from sleeping participants signiﬁcantly increased
integrin activation on CMV+ CD8+ T cells compared with plasma
collected at 2 am during nocturnal wakefulness (Fig. 4 A, left).
We could also replicate our ﬁnding on a circadian rhythm ob-
served in integrin activation by comparing effects of plasma
collected at 6 am from sleeping participants versus plasma col-
lected at 6 pm (during regular daytime wakefulness; Fig. 4 B,
left).
Blocking catecholamines and PGs in the plasma derived from
wake participants using a composite of β2-AR, DP1, and EP4 re-
ceptor antagonists (which were the antagonists shown to block
the effect of the respective receptor agonists; Fig. S1) enhanced
integrin activation to levels comparable to the sleep condition
(P < 0.01; Fig. 4). Adding a composite of catecholamines and PGs
(epinephrine, norepinephrine, PGE2, and PGD2) at very low
physiological concentrations mimicking sleep–wake differences
(Haack et al., 2009; Dimitrov et al., 2015) to the plasma derived
from sleeping participants signiﬁcantly inhibited integrin acti-
vation (P < 0.01; Fig. 4 A, right). These results corroborate and
add to our foregoing sleep experiment by proving that the effect
of sleep deprivation is mediated by soluble factors present in the
plasma and that these factors act via Gαs-coupled receptors.
Even very low concentrations of Gαs-coupled receptors agonists
that correspond to changes induced by a couple of hours without
sleep signiﬁcantly suppressed integrin activation, again dem-
onstrating the great potency of endogenous Gαs-coupled recep-
tor ligands to suppress T cell function.
General conclusions
We show here that several Gαs-coupled receptor ligands po-
tently inhibit TCR-mediated integrin activation on antigen-
speciﬁc CD8+ T cells, whereas sleep up-regulates integrin acti-
vation by suppressing Gαs-coupled receptor signaling. Given the
importance of integrin activation for the formation of immu-
nological synapses (Dustin and Springer, 1989; Abram and
Lowell, 2009; Dustin and Long, 2010; Fooksman et al., 2010;
Long, 2011), our data suggest a critical role of conditions like
sleep that are characterized by low levels of Gαs-coupled re-
ceptor ligands, in boosting T cell responses (Irwin et al., 1999;
Lange et al., 2011). These ﬁndings provide a potential mechanism
for some immune-enhancing effects of sleep on a new, so far
unrecognized, level, namely the formation of immunological
synapses by T cell adhesion to APCs or target cells. The ﬁndings
are also important for understanding immunosuppression pre-
sent in a variety of pathologies characterized by increased levels
of adenosine (e.g., hypoxia, sleep apnea, and tumor growth),
catecholamines (e.g., chronic stress and sleep disturbances),
or PGs (e.g., tumor growth and malaria) (Kilunga Kubata et al.,
1998; Hoskin et al., 2008; Sloan et al., 2010; Brudvik and
Figure 4. Regulation of integrin activation by
plasma collected during sleep versus wake-
fulness is mediated by Gαs-coupled receptor
signaling. (A and B)Means ± SEM of the MFI of
mICAM-1 binding are shown on CMV-speciﬁc
CD8+ T cells incubated with plasma collected
at 2 am during sleep versus wakefulness (A) and
at 6 am (during nocturnal sleep) versus 6 pm
(during daytime wakefulness; B). CMV-speciﬁc
T cells were incubated with plasma collected
at the indicated time points and conditions
(sleep vs. wake) in the presence or absence of an
antagonist composite (including β2-AR, EP4, and
DP1 antagonists) or in the presence or absence
of an agonist composite (including epinephrine,
norepinephrine, PGE2, and PGD2). All experi-
ments were performed in duplicates. Signiﬁ-
cance is indicated for pairwise comparisons
between conditions or treatments using paired
t tests. n = 6; **, P ≤ 0.01; ***, P < 0.001.
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Taske´n, 2012). Furthermore, the results suggest that Gαs-coupled
receptors of catecholamines, PGs, and adenosine might consti-
tute immune checkpoint inhibitors, which could bemanipulated
for therapeutic purposes in various diseases, such as cancer
(Leone et al., 2015b; Ohta, 2016; Ricon et al., 2019).
Materials and methods
Participants and study procedure
Ten physically and mentally healthy participants (ﬁve men and
ﬁve women) were included in the study (mean age, 24.7 yr;
range, 19–34 yr; mean body mass index, 22.4 kg/m2; range,
20–25 kg/m2). Participants were selectively recruited for being
HLA-A2+ and CMV seropositive. Five of these individuals also
had detectable levels of EBV-speciﬁc CD8+ T cells, allowing us to
quantify a second type of antigen-speciﬁc cells in this subsam-
ple. All participants were nonsmokers, did not suffer from sleep
disturbances, and were not taking any medications (except for
oral contraceptives in women) at the time of the experiments.
None had a medical history of any relevant chronic disease or
mental disorder. Acute illness was excluded by physical exam-
ination and routine laboratory investigation, including a
chemistry panel, C-reactive protein concentration (<6 mg/liter),
and a white blood cell count (<9,000/µl).
For investigation of the effect of sleep and the circadian
system on adhesion properties of antigen-speciﬁc T cells, sub-
jects participated in two experimental conditions, each starting
at 8 pm and ending at 6 pm the following day, according to a
within-subject crossover design. One condition (sleep) included
a regular sleep–wake cycle, whereas in the other condition
(wake), participants remained awake throughout the entire
experimental period. In the sleep condition, sleep was allowed
between 11 pm (lights off) and 7 am, whereas in the wake con-
dition, participants stayed awake in bed in a half-supine position
between 11 pm and 7 am. During this time they were listening to
music and talking to the experimenter at normal room light.
Both experimental sessions were separated by ≥2 wk for each
participant. To control for a possible inﬂuence of the hormonal
cycle in women, both experimental sessions took place within 3
to 6 d after the beginning of their menstrual cycle or the pill-free
period.
On both conditions, blood was sampled at 10 pm, and then at
2 am, 6 am, 10 am, 2 pm, and 6 pm the next day. Blood was
sampled via an intravenous forearm catheter, which was con-
nected to a long thin tube and enabled blood collection from an
adjacent room without disturbing the participant’s sleep. To
prevent clotting, ∼500 ml of saline solution were infused
throughout the night. The total volume of blood sampled during
a session was 120 ml. Blood samples were always processed
immediately after sampling. All participants spent one adapta-
tion night in the sleep laboratory before the experimental ses-
sions in order to become accustomed to the experimental setting.
For incubation of whole blood with various Gαs-coupled re-
ceptor agonists, blood was collected at 6 am from ﬁve sleeping
participants. We used blood from sleeping participants for these
in vitro experiments, as endogenous Gαs-coupled receptor ago-
nists are lower during sleep than during wakefulness.
For the plasma experiments testing the Gαs-coupled receptor
dependence of the sleep/wake effect, we collected heparin
plasma from six healthy participants at 2 am on one night while
they were asleep and on another night while they stayed awake.
Plasma was also sampled at 6 am during regular sleep and at
6 pm during regular daytime wakefulness for investigation of
circadian rhythm effects. Indomethacin (a PG synthetase in-
hibitor; Sigma-Aldrich) was added to the plasma at a concen-
tration of 10 µg/ml before storage of the samples at −80°C until
further use. These six participants were not tested for CMV
seropositivity, as only their plasma (but not the antigen-speciﬁc
T cells) was used for further experiments (described in
Gαs-coupled receptor dependence of the effects of sleep…).
Otherwise, the experimental procedures were comparable to the
main sleep experiment. The study was approved by the Ethics
Committee of the University of Tübingen, and all participants
gave written informed consent.
pMHC and ICAM-1 multimers
We produced biotinylated pHLA-A*0201 monomers (CMV A2/
NLVPMVATV [A2/NLV] and EBV A2/GLCTLVAML [A2/GLC])
in-house by conventional pMHC refolding, as previously
described (Hadrup et al., 2015). We generated ﬂuorescent pHLA-
A*0201 multimers by coincubating monomers with streptavidin-
PE or -APC (Thermo Fisher Scientiﬁc) at a 1:4 (streptavidin:
pHLA-A2 monomer) molar ratio. Multimers were aliquoted and
stored at −80°C in Tris-buffered saline buffer containing 16%
glycerol (Hadrup et al., 2015). The ﬁnal concentration of azide
was 0.035%.
We generated ﬂuorescent ICAM-1-Fc/anti-Fc multimeric
complexes by coincubating 200 µg/ml of recombinant human
ICAM-1-Fc (produced as previously described; Bengtsson et al.,
2013) with polyclonal anti-human Fc-FITC F(ab9)2 fragments
(Jackson ImmunoResearch) at a 1:4 (ICAM-1-Fc:IgG part of anti-
Fc-FITC fragments) molar ratio at 4°C for 3 h. We stored them in
aliquots at −20°C for ≤1 wk until use.
Cell stimulation and mICAM-1 staining
We used a ﬂow cytometry assay based on whole blood staining
that we recently developed to monitor β2-integrin activation on
antigen-speciﬁc CD8+ T cells (Dimitrov et al., 2018). This assay
measures integrin activation by visualizing the speciﬁc cellular
binding of mICAM-1, reﬂecting an increased afﬁnity and/or
avidity of β2-integrins following TCR-induced activation. We
incubated fresh heparinized whole blood (380 µl/test) for 5 min
at 37°C in a water bath in 5-ml Falcon tubes (BD Biosciences)
with 0.6 µg/ml CMV A2-NLV/PE or EBV A2-GLC/PE multimers
and 6.25 µg/ml mICAM-1/FITC. Immediately after incubation,
we ﬁxed the samples and lysed erythrocytes with FACS-Lysing
solution (BD Biosciences) containing 1 mM Ca2+ and 2 mMMg2+
for 5 min, followed by washing with PBS/0.5% albumin/0.1%
sodium azide. After centrifugation, we stained the cells for
surface markers in order to identify CD8+ T cells and their
subpopulations (early [CD27+CD28+], intermediate [CD27+CD28−],
and late [CD27−CD28−] differentiated cells). The monoclonal
antibodies CD4/BV421, CD3/BV510, CD8/BV605, CD28/PerCP-
Cy5.5, CD27/APC, CD14/APC-Cy7, and CD19/APC-Cy7 (all from
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BioLegend) were added to the cells for 15 min at room tem-
perature. All antibodies were used at pretested optimal con-
centrations. The samples were acquired on a LSR Fortessa (BD
Biosciences) and analyzed using FACS DiVa version 8.0. We
collected at least 50,000 CD8+ events for the antigen-speciﬁc
assays. Results are presented as percentage of cells within the
parent populations (only Fig. 1 and Fig. S2) or MFI of mICAM-
1 binding on total pMHC+ cells.
In vitro effect of Gαs-coupled receptor agonists
and antagonists
To investigate the effects of Gαs-coupled receptor agonists on
the TCR-induced β2-integrin activation, whole blood taken at 6 am
from ﬁve participants while asleep was preincubated for
5 min at 37°C in the presence or absence of (–)-isoproterenol
(5 × 10−11–10−8 M), (–)-epinephrine (5 × 10−11–10−8 M),
(–)-norepinephrine (10−9–10−6 M), PGD2 (10–10,000 pg/ml),
PGE2 (10–10,000 pg/ml), dopamine (10−8–10−6 M; all from
Sigma-Aldrich), adenosine (10−8–10−4 M), serotonin (10−8–10−4
M), or histamine (10−8–10−4 M; all from Carl Roth) before
staining with pMHC multimers and mICAM-1 as described
above. Due to the known rapid uptake of adenosine by eryth-
rocytes when using whole blood (Ramakers et al., 2008), the
assay for adenosine was also performed on PBMCs isolated in
mononuclear cell preparation tubes (CPT; BD Biosciences) from
three CMV-seropositive participants. In contrast to whole
blood, PBMCs had to be stimulated with peptides (in addition to
the pMHC multimers) to achieve optimal cell activation. Al-
terations in the MFI of mICAM-1 binding on the different in
vitro drug treatments are presented as percentage of the
control value (without Gαs-coupled receptor agonists), thereby
eliminating interindividual differences in MFI.
To investigate whether the effects of the various ligands can
be blocked by antagonists of the cognate Gαs-coupled receptors,
whole blood was sampled at 9 am from three to four CMV-
seropositive participants. The whole blood cells were then pre-
incubated with the following antagonists at the indicated con-
centration before incubation of the cells with the agonists as
described in Fig. S1: β2-AR antagonist ICI-118,551 (10−7 M), PGE2
EP4 receptor antagonist ONO-AE3-208 (3 × 10−6 M; both from
Sigma Aldrich), PGE2 EP2 receptor antagonist PF-04418948 (3 ×
10−6 M), and PGD2 DP1 receptor antagonist MK-0524 (3 × 10−6 M;
Santa Cruz Biotechnology). Following 5 min of incubation, the
cells were stained with CMV A2-NLV/PE and mICAM-1 for vi-
sualization of integrin activation.
Gαs-coupled receptor dependence of the effects of sleep (vs.
wakefulness) on β2-integrin activation
To demonstrate that the sleep/wake difference in integrin ac-
tivation was mediated by changes of soluble factors present in
plasma acting via Gαs-coupled receptors, CMV-speciﬁc T cells
were incubated with plasma collected during sleep or wakeful-
ness in the presence or absence of Gαs-coupled receptor antag-
onists or agonists. 80 µl of whole blood taken at 6 am from one
HLA-A2+ and CMV-seropositive participant during sleep (to
keep endogenous Gαs-coupled receptor ligands low) was im-
mediately preincubated in the presence or absence of a
composite of the following antagonists: the β2-AR antagonist ICI-
118,551 (10−7 M; Sigma-Aldrich), the PGE2 EP4 receptor antago-
nist ONO-AE3-208 (3 × 10−6 M; Sigma-Aldrich), and the PGD2
DP1 receptor antagonist MK-0524 (3 × 10−6 M; Santa Cruz Bio-
technology) for 5 min at 37°C. These were the antagonists shown
to block the effect of the respective agonist on integrin activation
(Fig. S1). Blood was then incubated for 5 min at 37°C with 320 µl
of heparin plasma that had been collected previously from
participants during sleep or wakefulness (as described in Par-
ticipants and study procedure), before the staining with CMV
A2-NLV/PE and mICAM-1 as described above. To test whether
Gαs-coupled receptor agonists at low levels corresponding to
sleep/wake differences can reverse the effect of sleep on in-
tegrin activation, a composite of agonists ((−)-epinephrine [10−10
M], (−)-norepinephrine [0.5 × 10−9 M], PGD2 [30 pg/ml], and
PGE2 [30 pg/ml]) was added to the whole blood collected from
the CMV seropositive donor and incubated together with plasma
derived from sleeping participants for 5 min at 37°C before the
staining with CMV A2-NLV/PE and mICAM-1. We used a com-
posite of the Gαs-coupled receptor antagonists and agonists for
these plasma experiments in order to achieve conditions most
comparable to those naturally present in the blood during sleep
or wakefulness (where several Gαs-coupled receptor ligands are
concomitantly suppressed or increased, respectively). We did
not include adenosine or adenosine receptor blockers in these
experiments because of the extremely short half-life (<1 s)
of (endogenous or exogenous) adenosine in whole blood
(Ramakers et al., 2008).
Statistical analysis
Data are presented as means ± SEM. For in vitro data, ﬁtted
standard curves were calculated by nonlinear regression using
SigmaPlot and analyzed using paired t tests. Statistical analyses
for the in vivo sleep experiments were generally based on
repeated-measures ANOVA with subsequent post hoc contrasts.
ANOVA factors were sleep/wake, representing the two experi-
mental conditions; period (night/day); and time, reﬂecting re-
spective single time points of the night (10 pm to 6 am) and the
day (10 am to 6 pm). The differences in baseline measures (at
10 pm) between the sleep and wake conditions were used as
covariates to correct for day-to-day variations in immune
parameters. Degrees of freedom were corrected using the
Greenhouse–Geisser procedure. To identify signiﬁcant rhythms,
Cosinor analysis was performed for the wake and sleep condi-
tion with Chronolab using a period of 24 h (Mojón et al., 1992).
Online supplemental material
Fig. S1 demonstrates that the inhibitory effect of epinephrine,
norepinephrine, PGE2, and PGD2 on integrin activation is abol-
ished by Gαs-coupled receptor antagonists. Fig. S2 shows the
effect of epinephrine, norepinephrine, PGE2, and PGD2 on in-
tegrin activation in CMV-speciﬁc CD8+ T cell subpopulations.
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